breakdown

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

Middle East Respiratory Syndrome (MERS)

By: Uzma Toppa, PharmD Candidate c/o 2014 - Middle East Respiratory Syndrome, also known as MERS, is a viral respiratory…

13 years ago

Ceftriaxone Induced Hemolytic Anemia

By: Samad Tirmizi, PharmD Candidate c/o 2014 - Hemolytic anemia (HA) is a type of anemia that occurs due to…

13 years ago

Alzheimer’s Disease On The Rise

By: Ada Seldin - An impending storm is threatening to stagger the health care system and the nation at large.…

13 years ago

HMG-CoA Reductase Inhibitors And Memory Loss

By: Yufan (Frank) Liu, Pharm.D. Candidate c/o 2013 - Results of numerous epidemiological studies have indicated that having high serum…

14 years ago